Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Thermo Scientific Introduces Detector-Agnostic Software

Published: Wednesday, October 17, 2012
Last Updated: Wednesday, October 17, 2012
Bookmark and Share
TraceFinder software version 2.1 performs routine analysis with GC, LC, HPLC, GC-MS and LC-MS, including non-mass spectrometry detectors.

Thermo Fisher Scientific Inc. has introduced Thermo Scientific TraceFinder software version 2.1 for routine, high analytical throughput analysis of gas and liquid chromatography data.
The software now supports Thermo Scientific non-mass spectrometry detectors, and this detector-agnostic package is designed for the quantitative and qualitative review of data for routine analyses.

Major applications include clinical research, forensic toxicology, food safety and environmental analysis.

TraceFinder™ software version 2.1 is designed to eliminate the need for multiple software packages when moving between most gas and liquid chromatographic techniques. This can provide more flexibility in the laboratory and reduce the need to learn new software packages.

TraceFinder software is designed to make routine GC, GC-MS, HPLC, and LC-MS quantitation and targeted analysis simple, fast and productive.

The software offers a simple workflow-driven method setup and automated data acquisition, data processing and reporting capabilities.

Methods developed with TraceFinder software can be shared between instruments and between laboratories. This sharing ability allows users to make methods readily available on new instruments.

When using triple quadrupole GC-MS and LC-MS systems, the Compound Data Store (CDS) provides an extensive list of selected reaction monitoring (SRM) experiments in environmental testing, food safety residue analysis, clinical research and forensic toxicology applications.

Data review is customizable and assigns multiple flags to aid with quick identification of problem areas within a data set.

To protect the integrity of analytical data, the software also includes a rights-based secure user login system.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher Scientific to Acquire Life Technologies Corporation
The definitive agreement will see Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share or approximately $13.6 billion.
Monday, April 15, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.
Towards Patient-Specific Drug Screening
A new breakthrough by the 3D stem cell printing team at Heriot-Watt could pave the way to individually tailored drug testing regimes, both reducing the need for animal testing and ensuring that patients receive drugs which are most effective for their individual needs.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
Manipulating microbes maximizes tumor immunity in mice.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos